{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:09Z","timestamp":1793608029418,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100032917","name":"Navamindradhiraj University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129141","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:12:44Z","timestamp":1789225964000},"page":"129141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy of lidocaine spray for pain reduction during rabies immunoglobulin infiltration: a double-blind, randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"92","author":[{"given":"Pichat","family":"Areeraksakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5926-353X","authenticated-orcid":false,"given":"Rittirak","family":"Othong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129141_bb0005","unstructured":"Centers for Disease Control and Prevention. Global rabies: what you should know n.d. https:\/\/www.cdc.gov\/rabies\/around-world\/index.html (accessed December 3, 2025)."},{"key":"10.1016\/j.vaccine.2026.129141_bb0010","series-title":"Mammal bites and rabies prevention","author":"Punrin","year":"2022"},{"key":"10.1016\/j.vaccine.2026.129141_bb0015","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.vaccine.2018.06.061","article-title":"Rabies vaccines: WHO position paper, April 2018 \u2013 recommendations","volume":"36","author":"World Health Organization","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129141_bb0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4103\/ijph.IJPH_846_20","article-title":"Efficacy of 2% lignocaine medicated pad for pain alleviation during rabies immunoglobulin administration: a randomized controlled trial","volume":"65","author":"Nujum","year":"2021","journal-title":"Indian J Public Health"},{"key":"10.1016\/j.vaccine.2026.129141_bb0025","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2081024","article-title":"Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures","volume":"18","author":"Haradanhalli","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.129141_bb0030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1503\/cmaj.150391","article-title":"Reducing pain during vaccine injections: clinical practice guideline","volume":"187","author":"Taddio","year":"2015","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2026.129141_bb0035","unstructured":"Endo Pharmaceuticals Inc. Lidocaine patch 5% 2015."},{"key":"10.1016\/j.vaccine.2026.129141_bb0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1185\/03007995.2014.973484","article-title":"Lidocaine patch for acute pain management: a meta-analysis of prospective controlled trials","volume":"31","author":"Bai","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.vaccine.2026.129141_bb0045","unstructured":"Pharmacy benefits management services, Medical advisory panel, VISN pharmacist executives. Lidocaine topical patch 5% literature review addendum 2015. https:\/\/downloads.regulations.gov\/HHS-OS-2018-0027-3980\/attachment_5.pdf (accessed July 5, 2023)."},{"key":"10.1016\/j.vaccine.2026.129141_bb0050","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2147\/JPR.S131029","article-title":"Effectiveness of various formulations of local anesthetics and additives for topical anesthesia \u2013 a prospective, randomized, double-blind, placebo-controlled study","volume":"10","author":"Weilbach","year":"2017","journal-title":"J Pain Res"},{"key":"10.1016\/j.vaccine.2026.129141_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112522","article-title":"Effectiveness of topical anesthetics in pain management for dermal injuries: a systematic review","volume":"10","author":"Navarro-Rodriguez","year":"2021","journal-title":"JCM"},{"key":"10.1016\/j.vaccine.2026.129141_bb0060","unstructured":"Astrazeneca. EMLA \u00ae anesthetic disc (lidocaine 2.5% and prilocaine 2.5% cream): product monograph. S\u00f6dert\u00e4lje, Sweden: n.d."},{"key":"10.1016\/j.vaccine.2026.129141_bb0065","series-title":"Xylocaine \u00ae Jelly 2%: prescribing information","author":"AstraZeneca","year":"2008"},{"key":"10.1016\/j.vaccine.2026.129141_bb0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/ija.ija_705_22","article-title":"A comparative study of 10% lidocaine spray versus eutectic mixture of 2.5% lidocaine and 2.5% prilocaine (EMLA) to attenuate pain of peripheral venous cannulation in children: a prospective randomized control trial at a tertiary care Centre","volume":"67","author":"Kulkarni","year":"2023","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.vaccine.2026.129141_bb0075","series-title":"Xylocaine spray\u00ae: Product monograph including patient medication information","author":"Aspen Pharmacare","year":"2021"},{"key":"10.1016\/j.vaccine.2026.129141_bb0080","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1526-4637.2009.00790.x","article-title":"Comparison of cutaneous anesthetic effect of 8% lidocaine spray with lidocaine patch using current perception threshold test","volume":"11","author":"Kanai","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.vaccine.2026.129141_bb0085","first-page":"75","article-title":"Xylocaine\u00ae 10% pump spray as topical anaesthetic for venepuncture pain","volume":"24","author":"van Straten","year":"2018","journal-title":"SAJAA"},{"key":"10.1016\/j.vaccine.2026.129141_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajem.2021.05.060","article-title":"10% lidocaine spray as a local anesthetic in blood gas sampling: a randomized, double-blind, placebo-controlled study","volume":"49","author":"Gur","year":"2021","journal-title":"AJEM"},{"key":"10.1016\/j.vaccine.2026.129141_bb0095","doi-asserted-by":"crossref","unstructured":"Beecham GB, Nessel TA, Goyal A. Lidocaine. Encyclopedia of toxicology, Fourth Edition: Volume 1-9 2024;5:V5\u2013825-V5\u2013828. https:\/\/doi.org\/10.1016\/B978-0-12-824315-2.00538-8.","DOI":"10.1016\/B978-0-12-824315-2.00538-8"},{"key":"10.1016\/j.vaccine.2026.129141_bb0100","series-title":"n4Studies: application for sample size calculation in health science research","author":"Ngamjarus","year":"2024"},{"key":"10.1016\/j.vaccine.2026.129141_bb0105","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2026.129141_bb0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1037\/1082-989X.13.1.19","article-title":"A probability-based measure of effect size: robustness to base rates and other factors","volume":"13","author":"Ruscio","year":"2008","journal-title":"Psychol Methods"},{"key":"10.1016\/j.vaccine.2026.129141_bb0115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/sim.2256","article-title":"Probabilistic index: an intuitive non-parametric approach to measuring the size of treatment effects","volume":"25","author":"Acion","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2026.129141_bb0120","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0196-0644(96)70238-X","article-title":"Clinical significance of reported changes in pain severity","volume":"27","author":"Todd","year":"1996","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.vaccine.2026.129141_bb0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1067\/mem.2001.118863","article-title":"Prospective validation of clinically important changes in pain severity measured on a visual analog scale","volume":"38","author":"Gallagher","year":"2001","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.vaccine.2026.129141_bb0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/EJA.0b013e32834592a8","article-title":"Measuring pain and analgesic response","volume":"28","author":"Myles","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.vaccine.2026.129141_bb0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.29271\/jcpsp.2023.05.491","article-title":"Comparison of the analgesic efficacy of lidocaine spray versus tramadol and fentanyl for pain control in rib fractures","volume":"33","author":"Erdem","year":"2023","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.vaccine.2026.129141_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1006908","article-title":"The distinctive role of menthol in pain and analgesia: mechanisms, practices, and advances","volume":"15","author":"Li","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.vaccine.2026.129141_bb0145","unstructured":"U.S. Food and Drug Administration. Over-the-counter (OTC) monograph M017: external analgesic drug products for over-the-counter human use 2023:4. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/omuf\/monographs\/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf (accessed July 26, 2026)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:39:47Z","timestamp":1793605187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"alternative-id":["S0264410X26009503"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129141","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of lidocaine spray for pain reduction during rabies immunoglobulin infiltration: a double-blind, randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129141"}}